MRPS16 Gene Combined Oxidative Phosphorylation Deficiency Type 2 Genetic Test
Welcome to DNA Labs UAE, where we offer the MRPS16 Gene Combined Oxidative Phosphorylation Deficiency Type 2 Genetic Test. This test is used to diagnose and manage individuals suspected of having COXPD2, a rare genetic disorder characterized by a defect in the mitochondria’s ability to produce energy.
Test Details
The MRPS16 gene is associated with Combined Oxidative Phosphorylation Deficiency Type 2 (COXPD2). Our NGS (Next-Generation Sequencing) Genetic Test utilizes high-throughput sequencing technologies to analyze multiple genes simultaneously. This allows for the detection of genetic variations, including mutations, deletions, or duplications, in a more efficient and cost-effective manner compared to traditional Sanger sequencing.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the MRPS16 Gene Combined Oxidative Phosphorylation Deficiency Type 2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with COXPD2. This information will help in the accurate interpretation of the test results.
Conclusion
The MRPS16 Gene Combined Oxidative Phosphorylation Deficiency Type 2 Genetic Test at DNA Labs UAE offers an efficient and cost-effective method for diagnosing and managing COXPD2. By identifying the underlying genetic cause of the disorder, this test can provide valuable insights for personalized treatment and care.
Test Name | MRPS16 Gene Combined oxidative phosphorylation deficiency type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MRPS16 Gene Combined oxidative phosphorylation deficiency type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 2 |
Test Details |
The MRPS16 gene is associated with Combined Oxidative Phosphorylation Deficiency Type 2 (COXPD2), which is a rare genetic disorder characterized by a defect in the mitochondria’s ability to produce energy. NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of genetic variations, including mutations, deletions, or duplications, in a more efficient and cost-effective manner compared to traditional Sanger sequencing. Therefore, an NGS Genetic Test for the MRPS16 gene would involve sequencing the specific region of the gene to identify any genetic variations that may be associated with COXPD2. This test can help in the diagnosis and management of individuals suspected of having COXPD2 by identifying the underlying genetic cause of the disorder. |